Revvity Inc (BSP:R1VT34)
R$ 23.77 0 (0%) Market Cap: 81.00 Bil Enterprise Value: 93.46 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 65/100

PerkinElmer Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 02:05PM GMT
Release Date Price: R$23.84
Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Hello and good morning, everybody. I'm Derik De Bruin, the Bank of America, Life Sciences and Diagnostics tools analyst. Thank you for joining us today at our Global Healthcare Conference. With us today is a conversation with PerkinElmer. With us is Prahlad Singh, the President and CEO; and also[Bryan Kipp from IR is joining. Gentlemen, welcome.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Thank you, Derik.

Derik De Bruin
BofA Merrill Lynch, Research Division - MD of Equity Research

Thank you. Thanks for doing this. Appreciate it. A lot going on. So before we sort of dive into the endless COVID questions, which I've got a lot from investors here -- and by the way, if anyone's listening, please go ahead and send me a semi -- questions either on the Veracast link. Or if you're listening outside, go ahead and chat or e-mail.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot